- Telehealth Visits
- Insurance plan information
Melanie C. Majure, MD
Breast Medical Oncology- Telehealth Visits
- Insurance plan information
Melanie C. Majure, MD
Breast Medical Oncology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Medical Oncology, American Board of Internal Med/Medical Oncology
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Hematology - Oncology, University of CA at San Francisco - Pathology GME
Residency
- Internal Medicine, Stanford University Medical Center-GME
Internship
- Internal Medicine, Stanford University Medical Center-GME
Degree
- MD, Stanford University School of Medicine
My expertise
Specialties
Locations
My research
Publications
Showing 1-6 of 95 reviews
- February 27, 20265 out of 5 Stars
I am absolutely pleased with my in-going relationship with Dr Majure. She has always allowed time to discuss alternative care which has been very crucial for me.
- February 19, 20265 out of 5 Stars
Dr. Majure is a wonderful doctor. I am so blessed and grateful for her!
- February 13, 20265 out of 5 Stars
Dr. Majure is the best doctor I have ever had!
- February 3, 20265 out of 5 Stars
I saw 3 providers yesterday. Each one was STELLAR, unparalleled expertise, enormous empathy for me, and so personally hopeful and helpful. The caliber and love abound at UCSF. I especially thank doctors Majure, Piper, and Ramsier in Derm.
- February 3, 20265 out of 5 Stars
Dr. Majure is an extremely professional and very caring Oncologist. I feel very fortunate to have her as my Medical Oncologist.
- January 30, 20265 out of 5 Stars
Dr. Majure is an excellent provider. She is professional, compassionate, and explains what she is prescribing. She always answers my questions, and listens to my concerns. Most of all, she cares about her patients.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.